For decades, the US Department of Health and Human Services’ Office of Inspector General (OIG) has analyzed clinical laboratory business arrangements by asking how much compliance risk they pose. With the release of Advisory Opinion 26-02 on February 18, 2026, the watchdog agency offered a rare approval to a structure that has historically invited scrutiny: […]
To access this post, you must purchase The Dark Report.